Leverages clinical whole-genome sequencing and machine learning bioinformatics to deliver hereditary disease and personalized drug-response insights for healthcare networks.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
MyOme develops a clinical genomics platform and advanced bioinformatics software designed to deliver lifetime, actionable health insights from a single DNA sample. The company utilizes whole-genome sequencing combined with machine learning to generate comprehensive diagnostic and proactive screening profiles, crossing single-gene hereditary data with polygenic risk scores that account for diverse multi-ancestry backgrounds and lifestyle factors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
MyOme Management Team
Investors
Foresite Capital
Founders Fund
HealthCare Ventures LLC
Sequoia
Softbank Capital
MyOme Valuations & Financials
View real-time NPM data on MyOme stock including daily MyOme stock price estimates, valuation history, and historical share price information. Access MyOme financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track MyOme pricing across six independent market signals. Looking for private company due diligence data sources on MyOme? Get in touch to learn more.
Similar Companies
like MyOme
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
TILT
Consumer
Cannabis business solutions that span hardware, branded products, and multi-state cultivation and wholesale operations.
Vntana
Media & Entertainment
Streamlines how brands convert design assets into interactive 3D content that publishes everywhere with ease.
dYdX
Web3 & Digital Assets
Decentralized trading platform offering perpetual contracts with leverage, advanced features, and self-custody for professional traders.
Shoonya Digital
Consumer
Provides multilingual learning games combined with early math and literacy to engage young learners.
Alec’s Ice Cream
Consumer
Crafts organic, regenerative dairy treats with clean ingredients and digestibility benefits.
Unico
Mobility & Transportation
Builds test equipment and control systems for electric vehicle components and powertrain validation.
Vannevar Labs
Industrials
Develops AI-powered analytics platforms to enhance national security operations through advanced threat detection and data analysis.
PrimeGlobal
Enterprise Software
Connects independent accounting firms to share expertise, resources and global service capabilities.
FAQ
We have answers
MyOme stock does not trade on public stock exchanges. MyOme stock is considered a private security and you need to be an accredited investor to trade shares. To invest in MyOme stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
MyOme Stock does not trade on public stock exchanges. In order to sell MyOme shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
MyOme does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view MyOme share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for MyOme stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell MyOme stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in MyOme stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
MyOme is a private company and has not had an IPO. There is currently no MyOme IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to MyOme IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
